SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-22-000026
Filing Date
2022-11-02
Accepted
2022-11-02 06:03:26
Documents
77
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20220930.htm   iXBRL 10-Q 2230564
2 EX-31.1 uthrex31109302022.htm EX-31.1 11705
3 EX-31.2 uthrex31209302022.htm EX-31.2 11711
4 EX-32.1 uthrex32109302022.htm EX-32.1 6575
5 EX-32.2 uthrex32209302022.htm EX-32.2 6702
  Complete submission text file 0001082554-22-000026.txt   9235834

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20220930.xsd EX-101.SCH 52418
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20220930_cal.xml EX-101.CAL 77750
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20220930_def.xml EX-101.DEF 299922
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20220930_lab.xml EX-101.LAB 711973
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20220930_pre.xml EX-101.PRE 456233
71 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20220930_htm.xml XML 1758843
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 221352158
SIC: 2834 Pharmaceutical Preparations